Skip to main content

Table 1 Patient characteristics by employment status and educational level

From: Non-employment and low educational level as risk factors for inequitable treatment and mortality in heart failure: a population-based cohort study of register data

Total (%) Distribution (%)
  Total cohort Employed Non-employed Post-secondary school Upper secondary school Compulsory school
  N = 3874 N = 3836 (with data on employment) N = 3767 (with data on education)
   2046 (53.3) 1790 (46.7) 719 (19.1) 1818 (48.3) 1230 (32.7)
Age (years)
 Median 57 56 58 56 57 58
 25th percentile 50 48 52 47 48 52
 75th percentile 61 60 62 61 61 62
Gender
 Women 1239 (32.0) 585 (28.6) 648 (36.2) 263 (36.6) 583 (32.1) 366 (29.8)
 Men 2635 (68.0) 1461 (71.4) 1142 (63.8) 456 (63.4) 1235 (67.9) 864 (70.2)
Income (€)a
 Median 13,673 17,490 11,240 17,279 13,808 12,356
 25th percentile 10,308 12,769 8817 11,548 10,587 9760
 75th percentile 19,962 23,466 14,000 24,365 19,548 18,346
Follow -up time (days)
 Range 1–1643 1–1641 1–1643 1–1635 1–1639 1–1643
 Median 737 777 688 738 726 746
 25th percentile 322 372 281 307 333 312
 75th percentile 1179 1207 1151 1135 1178 1192
Comorbidity
 Hypertension 1088 (28.4) 576 (28.2) 512 (28.6) 200 (27.8) 521 (28.7) 339 (27.6)
 Diabetes mellitus 585 (15.1) 198 (9.7) 377 (21.1) 97 (13.5) 267 (14.7) 196 (15.9)
 Angina pectoris 213 (5.5) 93 (4.5) 117 (6.5) 34 (4.7) 103 (5.7) 68 (5.5)
 Myocardial infarction 424 (10.9) 193 (9.4) 225 (12.6) 62 (8.6) 206 (11.3) 143 (11.6)
 Atrial fibrillation/flutter 958 (24.7) 517 (25.3) 429 (24.0) 176 (24.5) 434 (23.9) 323 (26.3)
 Pacemaker 115 (3.0) 56 (2.7) 58 (3.2) 28 (3.9) 49 (2.7) 34 (2.8)
 Stroke 120 (3.1) 36 (1.8) 84 (4.7) 17 (2.4) 59 (3.2) 42 (3.4)
 Renal dysfunction 208 (5.4) 69 (3.4) 137 (7.7) 29 (4.0) 107 (5.9) 67 (5.4)
 Vascular disease 65 (1.7) 25 (1.2) 40 (2.2) 8 (1.1) 31 (1.7) 25 (2.0)
 Rheumatic disease 65 (1.7) 20 (1.0) 45 (2.5) 10 (1.4) 28 (1.5) 27 (2.2)
 Lung disease 581 (15.0) 198 (9.7) 378 (21.1) 71 (9.9) 283 (15.6) 207 (16.8)
 Liver disease 92 (2.4) 33 (1.6) 59 (3.3) 13 (1.8) 45 (2.5) 32 (2.6)
 CABG 193 (5.0) 80 (3.9) 111 (6.2) 31 (4.3) 94 (5.2) 62 (5.0)
 Anaemia 176 (4.5) 44 (2.2) 131 (7.3) 23 (3.2) 91 (5.0) 58 (4.7)
 Cancer 118 (3.0) 64 (3.1) 53 (3.0) 22 (3.1) 50 (2.8) 44 (3.6)
 Dementia 8 (0.2) 3 (0.1) 5 (0.3) 1 (0.1) 5 (0.3) 2 (0.2)
 Psychiatric disease 359 (9.3) 97 (4.7) 257 (14.4) 43 (6.0) 171 (9.4) 137 (11.1)
RASb < 30 days (among 30-day survivors, N = 3731) 2802 (75.1) 1627 (82.2) 1157 (67.5) 524 (75.0) 1327 (76.0) 886 (75.0)
  1. RASb, Renin-angiotensin system blockers
  2. CABG, coronary artery bypass grafting
  3. a) Converted from Swedish krona; rate from the Swedish central bank (Riksbanken); https://www.riksbank.se/sv/statistik/ accessed 14 September 2020